
English
-
-
Controlling Dengue: Immunization Is a Pillar of Prevention
Medscape33 minutes -
Emerging Issues in Dengue Control
Takeda -
Dengue Prevention: Vaccination as Part of A Comprehensive Strategy for Disease Control
Takeda -
Dengue Vaccines
Takeda -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Impact of SARS-CoV-2 interventions on dengue transmission
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Dengue: Strategies to Limit Human Exposure to Disease-Carrying Mosquitos
Medscape33 minutes -
Mosquito-Borne Viral Diseases: Advice for Travelers to Endemic Areas
Medscape35 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Prevention of dengue
Takeda6 minutes -
Pandemic-associated mobility restrictions could cause increases in dengue virus transmission
Takeda2 minutes -
Professor Adi Utarini – Eliminating Dengue
35 minutes -
Field and classroom initiatives for portable sequence-based monitoring of dengue virus in Brazil
Takeda2 minutes -
Dengue in Latam - Understand Disease Control and the Value of Vaccination
Takeda8 minutes -
Dengue in APAC - Understand Disease Control and the Value of Vaccination
Takeda13 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes -
Hydrometeorological Hazards and Dengue Outbreak Prediction
ADVA19 minutes -
Mosquito Life Cycle
HHMI BioInteractive3 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda -
Dengue disease awareness
ISID39 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Effects of dengue
Takeda7 minutes -
Dengue serotypes
Takeda4 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023